Arylamine N-acetyltransferase

From Proteopedia
Jump to navigation Jump to search


Function

Arylamine N-acetyltransferase (NAT) catalyzes the transfer of an acetyl group from acetyl-CoA to an arylamine. Human NAT have 2 polymorphs with different substrate specificities. NAT1 acetylates p-aminisalycilates while NAT2 acetylates hydralazine.

Disease

Human NAT1 is overexpressed in some kinds of breast cancer.

Relevance

Acetylation is a major route of biotransformation for many arylamines and hydrazine drugs and known carcinogens like cigarette smoke. The levels of NAT in the body has important consequences with regard to an individual’s susceptibility to certain drug-induced toxicities and cancer.

Structural highlights

NAT acetylates using a (magenta). [1] TYX is colored in salmon.

3D structures of arylamine N-acetyltransferase

Arylamine N-acetyltransferase 3D structures


Human arylamine N-acetyltransferase 1 with active site Cys intermediate complex with Cl- (green) (PDB code 2pqt)

Drag the structure with the mouse to rotate

ReferencesReferences

  1. Wu H, Dombrovsky L, Tempel W, Martin F, Loppnau P, Goodfellow GH, Grant DM, Plotnikov AN. Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases. J Biol Chem. 2007 Oct 12;282(41):30189-97. Epub 2007 Jul 26. PMID:17656365 doi:10.1074/jbc.M704138200

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky